Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial

Overview of attention for article published in Nature Medicine, June 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 101 news outlets
blogs: 10 blogs
twitter: 55 X users
facebook: 2 Facebook pages

reddit: 4 Redditors
guideline: 1 clinical guideline source
bluesky: 1 Bluesky user

Readers on

mendeley: 117 Mendeley

So far, Altmetric has seen 10 posts from 10 blogs.

Low Dose Ketamine for Depression

Psychology Today, 25 Sep 2024

You may have heard about ketamine in the news, but did you know that the right dose of this medicine can stimulate your brain…

Randomized Phase 2 Trial: Extended-Release Ketamine Tablets Reduce Depression Scores in Treatment-Resistant Depression Without Significant Adverse Effects – Nat Med

SPECIALTIES, 14 Aug 2024

Study Design and Population: This phase 2 multicenter, randomized, placebo-controlled trial evaluated the efficacy and safety…

Extended-Release Oral Ketamine Effective for Treatment-Resistant Depression

Physician's Weekly, 18 Jul 2024

WEDNESDAY, July 17, 2024 (HealthDay News) — For patients with treatment-resistant depression, racemic ketamine, given as an…

Ketamine Pill Appears to Alleviate Severe Depression, Early Trial Shows

Science Alert, 29 Jun 2024

With no psychedelic side effects.

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity, including 6 additional blog posts.